May 11, 2012 – Researchers from the U.S. Food & Drug Administration (FDA) are expressing concern over the risk of bone fractures associated with the long-term use of a number of popular osteoporosis drugs from the bisphosphonate class. In an article published this week in the New England Journal of Medicine (NEJM), FDA researchers stated they were still uncertain as to the optimal duration for use of bisphosphonates, due to the high number of reports of atypical bone fractures in users of the drugs. Osteoporosis medications from the bisphosphonate class include Fosamax, Actonel, and Boniva.
Fosamax Femur Fracture Update 3/13/13: A new study has identified a causal link between Fosamax and nonhealing femur fractures. The research, which was published in last month’s edition of the Journal of Bone & Joint Surgery, found that nonhealing femur fractures are not just associated with Fosamax and other diabetes drugs, but directly caused by them. Click here to learn more.
Free Bisphosphonate Bone Fracture Lawsuit Evaluation: If you or a loved one has suffered a serious bone fracture after taking a bisphosphonate, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of the bisphosphonate and we can help.
What’s the problem?
The information in the NEJM article was based on data from a September 2011 FDA report that recommended women discontinue treatment with bisphosphonates after five years, in order to maximize benefits of the drugs and minimize health risks. The report was assessed by an independent advisory panel which voted to place updated bone fracture warnings on the medications, but stopped short of finalizing any length-of-use recommendations.
The article discusses how transitioning from a bisphosphonate to another type of osteoporosis drug may reduce the risk of bone fractures, but does not provide any definitive recommendations. The authors conclude by stating that more in-depth studies are needed before such decisions and determinations can be reached.
The FDA has received a large number of adverse event reports from bisphosphonate users who suffered spontaneous femur fractures after taking the drugs for a prolonged period of time. In most cases, these injuries occurred with little or no trauma at all.
Pharmaceutical giant Merck currently faces hundreds of Fosamax femur fracture lawsuits filed on behalf of women around the country who claim the company failed to adequately warn about the risks associated with its best-selling drug. The claims allege that Fosamax weakens the ability of the femur bone to repair itself, thus increasing the risk of spontaneous fractures.
Do I have a Bisphosphonate Bone Fracture Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in bisphosphonate lawsuits. We are handling individual litigation nationwide and currently accepting new bone fracture cases in all 50 states.
Free Bisphosphonate Bone Fracture Lawsuit Evaluation: If you or a loved one has suffered a serious bone fracture after taking a bisphosphonate, you should contact our law firm immediately. You may be entitled to compensation by filing a bisphosphonate bone fracture suit and we can help.